Femasys, Inc. (FEMY)
2.98
+0.02
(+0.68%)
USD |
NASDAQ |
Aug 24, 16:00
2.90
-0.08
(-2.68%)
After-Hours: 20:00
Femasys Enterprise Value : 12.36M for Aug. 24, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 24, 2026 | 12.36M |
| August 21, 2026 | 12.30M |
| August 20, 2026 | 11.60M |
| August 19, 2026 | 11.54M |
| August 18, 2026 | 10.000M |
| August 17, 2026 | 9.878M |
| August 14, 2026 | 10.27M |
| August 13, 2026 | 10.27M |
| August 12, 2026 | 10.45M |
| August 11, 2026 | 10.45M |
| August 10, 2026 | 10.51M |
| August 07, 2026 | 11.39M |
| August 06, 2026 | 12.27M |
| August 05, 2026 | 12.45M |
| August 04, 2026 | 12.57M |
| August 03, 2026 | 12.33M |
| July 31, 2026 | 12.00M |
| July 30, 2026 | 12.15M |
| July 29, 2026 | 11.75M |
| July 28, 2026 | 12.18M |
| July 27, 2026 | 12.60M |
| July 24, 2026 | 14.57M |
| July 23, 2026 | 14.81M |
| July 22, 2026 | 13.99M |
| July 21, 2026 | 15.17M |
| Date | Value |
|---|---|
| July 20, 2026 | 13.24M |
| July 17, 2026 | 12.45M |
| July 16, 2026 | 12.57M |
| July 15, 2026 | 14.14M |
| July 14, 2026 | 14.23M |
| July 13, 2026 | 13.84M |
| July 10, 2026 | 15.41M |
| July 09, 2026 | 14.99M |
| July 08, 2026 | 15.32M |
| July 07, 2026 | 15.05M |
| July 06, 2026 | 15.68M |
| July 02, 2026 | 15.96M |
| July 01, 2026 | 16.50M |
| June 30, 2026 | 15.99M |
| June 29, 2026 | 10.63M |
| June 26, 2026 | 10.82M |
| June 25, 2026 | 10.21M |
| June 24, 2026 | 10.42M |
| June 23, 2026 | 11.45M |
| June 22, 2026 | 11.66M |
| June 18, 2026 | 11.54M |
| June 17, 2026 | 11.99M |
| June 16, 2026 | 10.94M |
| June 15, 2026 | 11.36M |
| June 12, 2026 | 11.96M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Abbott Laboratories | 229.54B |
| AngioDynamics, Inc. | 614.71M |
| Alphatec Holdings, Inc. | 1.920B |
| AtriCure, Inc. | 2.413B |
| Baxter International, Inc. | 20.38B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -4.469M |
| Revenue (Quarterly) | 0.3318M |
| Total Expenses (Quarterly) | 4.801M |
| EPS Diluted (Quarterly) | -1.331 |
| Gross Profit Margin (Quarterly) | -2.41% |
| Profit Margin (Quarterly) | -1.35K% |
| Earnings Yield | -155.0% |
| Normalized Earnings Yield | -201.30 |